Neurogene Overview
Neurogene Target Price
Analysts' 12-month price predictions for NGNE.
Get informed when a big investor buys or sells
+ FollowShare Price
$30.86
Average Target Price
$69.67
125.8% upside
125.8% upside3 analysts in the last 4 months
High: $70 | Low: $69
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-09 | H.C. WainwrightMitchel Kapoor | $70 | 126.8% upside |  |
| 2026-06-03 | UBS | $70 | 126.8% upside | |
| 2026-04-28 | Guggenheim | $69 | 123.6% upside | |
| 2025-10-02 | H.C. Wainwright | $45 | 45.8% upside | |
| 2025-04-14 | BMO CapitalKeith Tapper | $16 |  48.2% downside | |
| 2025-03-25 | Robert W. BairdJoel Beatty | $38 | 23.1% upside | |
| 2025-03-25 | H.C. WainwrightMitchell Kapoor | $50 | 62% upside | |
| 2024-11-20 | Stifel NicolausPaul Matteis | $46 | 49.1% upside | |
| 2024-11-19 | BMO CapitalKeith Tapper | $45 | 45.8% upside | |
| 2024-11-12 | BMO CapitalKeith Tapper | $60 | 94.4% upside | |
| 2024-11-12 | Stifel NicolausPaul Matteis | $60 | 94.4% upside | |
| 2024-08-12 | H.C. WainwrightMitchell Kapoor | $49 | 58.8% upside | |
| 2024-06-26 | BMO CapitalKeith Tapper | $65 | 110.6% upside | |
| 2024-06-10 | Robert W. BairdJoel Beatty | $54 | 75% upside | |
| 2024-05-13 | H.C. WainwrightMitchel Kapoor | $51 | 65.3% upside | |